DOCSLIB.ORG
Explore
Sign Up
Log In
Upload
Search
Home
» Tags
» URB602
URB602
Fig. 1A
615 Neuroscience-Cayman-Bertin
Cannabinoids and Endocannabinoid System Changes in Intestinal Inflammation and Colorectal Cancer
2-Arachidonoylglycerol a Signaling Lipid with Manifold Actions in the Brain
SYNTHESIS of 3-HETEROCYCLE PHENYL N-ALKYL CARBAMATES and THEIR ACTIVITY AS FAAH INHIBITORS Doctoral Dissertation
Laws, Rules, and Regulations
A Budding Source of Targets for Treating Inflammatory and Neuropathic Pain
2012 Meeting Program
Compartmentalization of Endocannabinoids Into Lipid Rafts In
Cannabinoids in Biology and Medicine
CAY10499, a Novel Monoglyceride Lipase Inhibitor Evidenced by an Expeditious Mglassay Giulio G
The Endocannabinoid System As a Potential Therapeutic Target for Pain Modulation
Pretreatment with the Monoacylglycerol Lipase Inhibitor URB602 Protects from the Long-Term Consequences of Neonatal Hypoxic–Is
Qt5k28c476.Pdf
A Guide to Targeting the Endocannabinoid System in Drug Design
The Endocannabinoid Enzyme
Schedules of Controlled Substances in Conflict Herewith Are Hereby Repealed
Activation of Orexin 1 Receptors in the Periaqueductal Gray of Male Rats Leads to Antinociception Via Retrograde Endocannabinoid
Top View
Endocannabinoid System in a Planarian Model
Bioactive Molecules • Building Blocks • Intermediates
Npgrj Nchembio 129 1..8
The Endogenous Cannabinoid System: a Budding Source of Targets for Treating Inflammatory and Neuropathic Pain
Revised Models of Endocannabinoid Signaling at Inhibitory Synapses in the Brain Min, R
Jscdhjournal of Sickle Cell Disease
Benyó Zoltán Semmelweis Egyetem
JPET #155465 1 Blockade of Endocannabinoid-Degrading Enzymes
Datasheet Inhibitors / Agonists / Screening Libraries a DRUG SCREENING EXPERT
Chem Soc Rev
(12) United States Patent (10) Patent No.: US 8,778,643 B2 Franz Et Al
Molecular Mechanism of Cannabinoids in Cancer Progression
A Guide to Targeting the Endocannabinoid System in Drug Design
Catalog Update01 - International Update 31/01/2013 08:18 Page 1
Endocrinology
Mobility of NMDA Autoreceptors in Presynaptic
Bioactive Compound Library Plus (96-Well)
A Guide to Targeting the Endocannabinoid System in Drug Design
Endocannabinoids Decrease Neuropathic Pain-Related Behavior in Mice Through the Activation of One Or Both Peripheral CB1 and CB2 Receptors
Modulation of the Anti-Nociceptive Effects of 2-Arachidonoyl Glycerol by Peripherally Administered FAAH and MGL Inhibitors in a Neuropathic Pain Model
(12) Patent Application Publication (10) Pub. No.: US 2013/0217764 A1 Piomelli Et Al
Mvy\P-035 New Jersey Department of Health Medicinal Marijuana Program PO 360 Trenton, NJ 08625-0360 MEDICINAL MARIJUANA PETITION (N.J.A.C
Avhandling Inlaga
Identification of a Novel Endocannabinoid-Hydrolyzing Enzyme Expressed by Microglial Cells
Cannabinoid Receptor Ligands
Catalog Update04 - UK Update 31/01/2013 08:16 Page 1
The Endocannabinoid System in Migraine: from Bench to Pharmacy and Back
Effects of Enhancing Anandamide Levels on Hippocampal
Endocannabinoid System in Neurodegenerative Disorders
Qt4r29v8bc.Pdf
Profiling Rat Brain Monoacylglycerol Lipase Activity Using an Ammonia
(CB2R) Agonists Modulate Neuropathic Pain and Cytokine Expression Jenny Wilkerson
Peripheral Antinociceptive Effects of Inhibitors of Monoacylglycerol
Comprehensive Analysis of Emerging New Psychoactive Substances By
Pharmacological and Therapeutic Secrets of Plant and Brain (Endo)Cannabinoids
Enzymatic Pathways That Regulate Endocannabinoid Signaling in the Nervous System
ICRS2012 PROGRAMME and ABSTRACTS
Pharmacological Research the Endocannabinoid System: Its General Strategy of Action, Tools for Its Pharmacological Manipulation
Differential Roles of the Two Major Endocannabinoid Hydrolyzing Enzymes in Cannabinoid Receptor Tolerance and Somatic Withdrawal